Orexo AB is a specialty pharmaceutical company that develops and commercializes its products with patented drug delivery technologies as the basis for development. The company’s host of products treats pain in cancer patients, insomnia and insomnia-related complications, gastric ulcers, and other health complications. Headquartered in Sweden, the company has a footprint in Europe, Asia, and the United States. For more information, please visit the company’s website at www.orexo.com.